Skip to main content
Erschienen in: Journal of Gastroenterology 3/2013

01.03.2013 | Original Article—Alimentary Tract

Lifestyle factors associated with gastroesophageal reflux disease in the Japanese population

verfasst von: Nobuyuki Matsuki, Tsuyoshi Fujita, Naoya Watanabe, Atsushi Sugahara, Akihiko Watanabe, Tsukasa Ishida, Yoshinori Morita, Masaru Yoshida, Hiromu Kutsumi, Takanobu Hayakumo, Hidekazu Mukai, Takeshi Azuma

Erschienen in: Journal of Gastroenterology | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

We aimed to clarify the lifestyle factors associated with erosive esophagitis and non-erosive reflux disease (NERD) in a Japanese population.

Methods

Among 886 subjects who underwent health screening, we selected, according to their scores on the FSSG (frequency scale for symptoms of gastroesophageal reflux disease; GERD) questionnaire and the findings of upper gastrointestinal endoscopy, 138 subjects with erosive esophagitis (EE), 148 subjects with NERD (absence of esophagitis, FSSG score ≥8, and acid reflux-related symptoms score ≥4), and 565 control subjects (absence of esophagitis and FSSG score ≤7). We compared clinical characteristics and various lifestyle factors in these three groups.

Results

The lifestyle factors significantly associated with NERD compared with findings in the control group were intake of egg (odds ratio [OR] 1.89, 95 % confidence interval [CI] 1.01–3.50), sleep shortage (OR 2.44, 95 % CI 1.54–3.88), and strong psychological stress (OR 1.77, 95 % CI 1.18–2.62). In male subjects, current smoking (OR 2.06, 95 % CI 1.13–3.74; OR 1.87, 95 % CI 1.09–3.20) was a significant risk factor for both NERD and EE. Moreover, alcohol >200 kcal/day (OR 3.99, 95 % CI 1.03–15.55) and intake of a large quantity of food at supper (OR 7.85, 95 % CI 1.66–37.05) were significant risk factors for EE in subjects with hiatal hernia. Intake of a large quantity of food at supper (OR 2.09, 95 % CI 1.06–4.13) was more common in the NERD group than in the EE group.

Conclusions

There were differences in the associated lifestyle factors between patients with NERD and those with EE, and there was also a gender-related difference between these groups.
Literatur
1.
Zurück zum Zitat Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2005;54(5):710–7.PubMedCrossRef Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2005;54(5):710–7.PubMedCrossRef
2.
Zurück zum Zitat Delaney BC. Review article: prevalence and epidemiology of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2004;20(Suppl 8):2–4.PubMedCrossRef Delaney BC. Review article: prevalence and epidemiology of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2004;20(Suppl 8):2–4.PubMedCrossRef
3.
Zurück zum Zitat Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J. Prevalence of gastro-oesophageal reflux symptoms and the influence of age and sex. Scand J Gastroenterol. 2004;39(11):1040–5.PubMedCrossRef Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J. Prevalence of gastro-oesophageal reflux symptoms and the influence of age and sex. Scand J Gastroenterol. 2004;39(11):1040–5.PubMedCrossRef
4.
Zurück zum Zitat Goh KL. Changing epidemiology of gastroesophageal reflux disease in the Asian-Pacific region: an overview. J Gastroenterol Hepatol. 2004;19(Suppl 3):S22–5.PubMedCrossRef Goh KL. Changing epidemiology of gastroesophageal reflux disease in the Asian-Pacific region: an overview. J Gastroenterol Hepatol. 2004;19(Suppl 3):S22–5.PubMedCrossRef
5.
Zurück zum Zitat Fujimoto K. Review article: prevalence and epidemiology of gastro-oesophageal reflux disease in Japan. Aliment Pharmacol Ther. 2004;20(Suppl 8):5–8.PubMedCrossRef Fujimoto K. Review article: prevalence and epidemiology of gastro-oesophageal reflux disease in Japan. Aliment Pharmacol Ther. 2004;20(Suppl 8):5–8.PubMedCrossRef
6.
Zurück zum Zitat Fujiwara Y, Arakawa T. Epidemiology and clinical characteristics of GERD in the Japanese population. J Gastroenterol. 2009;44(6):518–34.PubMedCrossRef Fujiwara Y, Arakawa T. Epidemiology and clinical characteristics of GERD in the Japanese population. J Gastroenterol. 2009;44(6):518–34.PubMedCrossRef
7.
Zurück zum Zitat Hershcovici T, Fass R. Nonerosive reflux disease (NERD)—an update. J Neurogastroenterol Motil. 2010;16(1):8–21.PubMedCrossRef Hershcovici T, Fass R. Nonerosive reflux disease (NERD)—an update. J Neurogastroenterol Motil. 2010;16(1):8–21.PubMedCrossRef
8.
Zurück zum Zitat Johansson KE, Ask P, Boeryd B, Fransson SG, Tibbling L. Oesophagitis, signs of reflux, and gastric acid secretion in patients with symptoms of gastro-oesophageal reflux disease. Scand J Gastroenterol. 1986;21(7):837–47.PubMedCrossRef Johansson KE, Ask P, Boeryd B, Fransson SG, Tibbling L. Oesophagitis, signs of reflux, and gastric acid secretion in patients with symptoms of gastro-oesophageal reflux disease. Scand J Gastroenterol. 1986;21(7):837–47.PubMedCrossRef
9.
Zurück zum Zitat Winters C Jr, Spurling TJ, Chobanian SJ, Curtis DJ, Esposito RL, Hacker JF 3rd, et al. Barrett’s esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology. 1987;92(1):118–24.PubMed Winters C Jr, Spurling TJ, Chobanian SJ, Curtis DJ, Esposito RL, Hacker JF 3rd, et al. Barrett’s esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology. 1987;92(1):118–24.PubMed
10.
Zurück zum Zitat Lind T, Havelund T, Carlsson R, Anker-Hansen O, Glise H, Hernqvist H, et al. Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol. 1997;32(10):974–9.PubMedCrossRef Lind T, Havelund T, Carlsson R, Anker-Hansen O, Glise H, Hernqvist H, et al. Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol. 1997;32(10):974–9.PubMedCrossRef
11.
Zurück zum Zitat Galmiche JP, Barthelemy P, Hamelin B. Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride. Aliment Pharmacol Ther. 1997;11(4):765–73.PubMedCrossRef Galmiche JP, Barthelemy P, Hamelin B. Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride. Aliment Pharmacol Ther. 1997;11(4):765–73.PubMedCrossRef
12.
Zurück zum Zitat Carlsson R, Dent J, Watts R, Riley S, Sheikh R, Hatlebakk J, et al. Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group. Eur J Gastroenterol Hepatol. 1998;10(2):119–24.PubMedCrossRef Carlsson R, Dent J, Watts R, Riley S, Sheikh R, Hatlebakk J, et al. Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group. Eur J Gastroenterol Hepatol. 1998;10(2):119–24.PubMedCrossRef
13.
Zurück zum Zitat Robinson M, Earnest D, Rodriguez-Stanley S, Greenwood-Van Meerveld B, Jaffe P, Silver MT, et al. Heartburn requiring frequent antacid use may indicate significant illness. Arch Intern Med. 1998;158(21):2373–6.PubMedCrossRef Robinson M, Earnest D, Rodriguez-Stanley S, Greenwood-Van Meerveld B, Jaffe P, Silver MT, et al. Heartburn requiring frequent antacid use may indicate significant illness. Arch Intern Med. 1998;158(21):2373–6.PubMedCrossRef
14.
Zurück zum Zitat Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, et al. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol. 2005;40(3):275.PubMedCrossRef Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, et al. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol. 2005;40(3):275.PubMedCrossRef
15.
Zurück zum Zitat Zagari RM, Fuccio L, Wallander MA, Johansson S, Fiocca R, Casanova S, et al. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett’s oesophagus in the general population: the Loiano–Monghidoro study. Gut. 2008;57(10):1354–9.PubMedCrossRef Zagari RM, Fuccio L, Wallander MA, Johansson S, Fiocca R, Casanova S, et al. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett’s oesophagus in the general population: the Loiano–Monghidoro study. Gut. 2008;57(10):1354–9.PubMedCrossRef
16.
Zurück zum Zitat Miwa H, Sasaki M, Furuta T, Koike T, Habu Y, Ito M, et al. Efficacy of rabeprazole on heartburn symptom resolution in patients with non-erosive and erosive gastro-oesophageal reflux disease: a multicenter study from Japan. Aliment Pharmacol Ther. 2007;26(1):69–77.PubMedCrossRef Miwa H, Sasaki M, Furuta T, Koike T, Habu Y, Ito M, et al. Efficacy of rabeprazole on heartburn symptom resolution in patients with non-erosive and erosive gastro-oesophageal reflux disease: a multicenter study from Japan. Aliment Pharmacol Ther. 2007;26(1):69–77.PubMedCrossRef
17.
Zurück zum Zitat Dean BB, Gano AD Jr, Knight K, Ofman JJ, Fass R. Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol. 2004;2(8):656–64.PubMedCrossRef Dean BB, Gano AD Jr, Knight K, Ofman JJ, Fass R. Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol. 2004;2(8):656–64.PubMedCrossRef
18.
Zurück zum Zitat Miyamoto M, Manabe N, Haruma K. Efficacy of the addition of prokinetics for proton pump inhibitor (PPI) resistant non-erosive reflux disease (NERD) patients: significance of frequency scale for the symptom of GERD (FSSG) on decision of treatment strategy. Intern Med. 2010;49(15):1469–76.PubMedCrossRef Miyamoto M, Manabe N, Haruma K. Efficacy of the addition of prokinetics for proton pump inhibitor (PPI) resistant non-erosive reflux disease (NERD) patients: significance of frequency scale for the symptom of GERD (FSSG) on decision of treatment strategy. Intern Med. 2010;49(15):1469–76.PubMedCrossRef
19.
Zurück zum Zitat Kusano M, Shimoyama Y, Sugimoto S, Kawamura O, Maeda M, Minashi K, et al. Development and evaluation of FSSG: frequency scale for the symptoms of GERD. J Gastroenterol. 2004;39(9):888–91.PubMedCrossRef Kusano M, Shimoyama Y, Sugimoto S, Kawamura O, Maeda M, Minashi K, et al. Development and evaluation of FSSG: frequency scale for the symptoms of GERD. J Gastroenterol. 2004;39(9):888–91.PubMedCrossRef
20.
Zurück zum Zitat Danjo A, Yamaguchi K, Fujimoto K, Saitoh T, Inamori M, Ando T, et al. Comparison of endoscopic findings with symptom assessment systems (FSSG and QUEST) for gastroesophageal reflux disease in Japanese centres. J Gastroenterol Hepatol. 2009;24(4):633–8.PubMedCrossRef Danjo A, Yamaguchi K, Fujimoto K, Saitoh T, Inamori M, Ando T, et al. Comparison of endoscopic findings with symptom assessment systems (FSSG and QUEST) for gastroesophageal reflux disease in Japanese centres. J Gastroenterol Hepatol. 2009;24(4):633–8.PubMedCrossRef
21.
Zurück zum Zitat Sasaki S, Yanagibori R, Amano K. Validity of a self-administered diet history questionnaire for assessment of sodium and potassium: comparison with single 24-hour urinary excretion. Jpn Circ J. 1998;62(6):431–5.PubMedCrossRef Sasaki S, Yanagibori R, Amano K. Validity of a self-administered diet history questionnaire for assessment of sodium and potassium: comparison with single 24-hour urinary excretion. Jpn Circ J. 1998;62(6):431–5.PubMedCrossRef
22.
Zurück zum Zitat Sasaki S, Yanagibori R, Amano K. Self-administered diet history questionnaire developed for health education: a relative validation of the test-version by comparison with 3-day diet record in women. J Epidemiol. 1998;8(4):203–15.PubMedCrossRef Sasaki S, Yanagibori R, Amano K. Self-administered diet history questionnaire developed for health education: a relative validation of the test-version by comparison with 3-day diet record in women. J Epidemiol. 1998;8(4):203–15.PubMedCrossRef
23.
Zurück zum Zitat Sasaki S, Ushio F, Amano K, Morihara M, Todoriki O, Uehara Y, et al. Serum biomarker-based validation of a self-administered diet history questionnaire for Japanese subjects. J Nutr Sci Vitaminol (Tokyo). 2000;46(6):285–96.CrossRef Sasaki S, Ushio F, Amano K, Morihara M, Todoriki O, Uehara Y, et al. Serum biomarker-based validation of a self-administered diet history questionnaire for Japanese subjects. J Nutr Sci Vitaminol (Tokyo). 2000;46(6):285–96.CrossRef
24.
Zurück zum Zitat Okubo H, Sasaki S, Rafamantanantsoa HH, Ishikawa-Takata K, Okazaki H, Tabata I. Validation of self-reported energy intake by a self-administered diet history questionnaire using the doubly labeled water method in 140 Japanese adults. Eur J Clin Nutr. 2008;62(11):1343–50.PubMedCrossRef Okubo H, Sasaki S, Rafamantanantsoa HH, Ishikawa-Takata K, Okazaki H, Tabata I. Validation of self-reported energy intake by a self-administered diet history questionnaire using the doubly labeled water method in 140 Japanese adults. Eur J Clin Nutr. 2008;62(11):1343–50.PubMedCrossRef
25.
Zurück zum Zitat Murakami K, Sasaki S, Takahashi Y, Okubo H, Hirota N, Notsu A, et al. Reproducibility and relative validity of dietary glycaemic index and load assessed with a self-administered diet-history questionnaire in Japanese adults. Br J Nutr. 2008;99(3):639–48.PubMedCrossRef Murakami K, Sasaki S, Takahashi Y, Okubo H, Hirota N, Notsu A, et al. Reproducibility and relative validity of dietary glycaemic index and load assessed with a self-administered diet-history questionnaire in Japanese adults. Br J Nutr. 2008;99(3):639–48.PubMedCrossRef
26.
Zurück zum Zitat Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy. 1969;3:87–97.CrossRef Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy. 1969;3:87–97.CrossRef
27.
Zurück zum Zitat Festi D, Scaioli E, Baldi F, Vestito A, Pasqui F, Di Biase AR, et al. Body weight, lifestyle, dietary habits and gastroesophageal reflux disease. World J Gastroenterol. 2009;15(14):1690–701.PubMedCrossRef Festi D, Scaioli E, Baldi F, Vestito A, Pasqui F, Di Biase AR, et al. Body weight, lifestyle, dietary habits and gastroesophageal reflux disease. World J Gastroenterol. 2009;15(14):1690–701.PubMedCrossRef
28.
Zurück zum Zitat Vemulapalli R. Diet and lifestyle modifications in the management of gastroesophageal reflux disease. Nutr Clin Pract. 2008;23(3):293–8.PubMedCrossRef Vemulapalli R. Diet and lifestyle modifications in the management of gastroesophageal reflux disease. Nutr Clin Pract. 2008;23(3):293–8.PubMedCrossRef
29.
Zurück zum Zitat El-Serag HB, Satia JA, Rabeneck L. Dietary intake and the risk of gastro-oesophageal reflux disease: a cross sectional study in volunteers. Gut. 2005;54(1):11–7.PubMedCrossRef El-Serag HB, Satia JA, Rabeneck L. Dietary intake and the risk of gastro-oesophageal reflux disease: a cross sectional study in volunteers. Gut. 2005;54(1):11–7.PubMedCrossRef
30.
Zurück zum Zitat Mitsukawa T, Takemura J, Ohgo S, Mizuta M, Ii T, Kuribayashi T, et al. Gallbladder function and plasma cholecystokinin levels in diabetes mellitus. Am J Gastroenterol. 1990;85(8):981–5.PubMed Mitsukawa T, Takemura J, Ohgo S, Mizuta M, Ii T, Kuribayashi T, et al. Gallbladder function and plasma cholecystokinin levels in diabetes mellitus. Am J Gastroenterol. 1990;85(8):981–5.PubMed
31.
Zurück zum Zitat Hershcovici T, Mashimo H, Fass R. The lower esophageal sphincter. Neurogastroenterol Motil. 2011;23(9):819–30.PubMedCrossRef Hershcovici T, Mashimo H, Fass R. The lower esophageal sphincter. Neurogastroenterol Motil. 2011;23(9):819–30.PubMedCrossRef
32.
Zurück zum Zitat Thomas GA, Rhodes J, Ingram JR. Mechanisms of disease: nicotine—a review of its actions in the context of gastrointestinal disease. Nat Clin Pract Gastroenterol Hepatol. 2005;2(11):536–44.PubMedCrossRef Thomas GA, Rhodes J, Ingram JR. Mechanisms of disease: nicotine—a review of its actions in the context of gastrointestinal disease. Nat Clin Pract Gastroenterol Hepatol. 2005;2(11):536–44.PubMedCrossRef
33.
Zurück zum Zitat Dodds WJ, Dent J, Hogan WJ, Helm JF, Hauser R, Patel GK, et al. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N Engl J Med. 1982;307(25):1547–52.PubMedCrossRef Dodds WJ, Dent J, Hogan WJ, Helm JF, Hauser R, Patel GK, et al. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N Engl J Med. 1982;307(25):1547–52.PubMedCrossRef
34.
Zurück zum Zitat Fujiwara Y, Kubo M, Kohata Y, Machida H, Okazaki H, Yamagami H, et al. Cigarette smoking and its association with overlapping gastroesophageal reflux disease, functional dyspepsia, or irritable bowel syndrome. Intern Med. 2011;50(21):2443–7.PubMedCrossRef Fujiwara Y, Kubo M, Kohata Y, Machida H, Okazaki H, Yamagami H, et al. Cigarette smoking and its association with overlapping gastroesophageal reflux disease, functional dyspepsia, or irritable bowel syndrome. Intern Med. 2011;50(21):2443–7.PubMedCrossRef
35.
Zurück zum Zitat Isolauri J, Laippala P. Prevalence of symptoms suggestive of gastro-oesophageal reflux disease in an adult population. Ann Med. 1995;27(1):67–70.PubMedCrossRef Isolauri J, Laippala P. Prevalence of symptoms suggestive of gastro-oesophageal reflux disease in an adult population. Ann Med. 1995;27(1):67–70.PubMedCrossRef
36.
Zurück zum Zitat Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med. 1999;106(6):642–9.PubMedCrossRef Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med. 1999;106(6):642–9.PubMedCrossRef
37.
Zurück zum Zitat Watanabe Y, Fujiwara Y, Shiba M, Watanabe T, Tominaga K, Oshitani N, et al. Cigarette smoking and alcohol consumption associated with gastro-oesophageal reflux disease in Japanese men. Scand J Gastroenterol. 2003;38(8):807–11.PubMedCrossRef Watanabe Y, Fujiwara Y, Shiba M, Watanabe T, Tominaga K, Oshitani N, et al. Cigarette smoking and alcohol consumption associated with gastro-oesophageal reflux disease in Japanese men. Scand J Gastroenterol. 2003;38(8):807–11.PubMedCrossRef
38.
Zurück zum Zitat Gunji T, Sato H, Iijima K, Fujibayashi K, Okumura M, Sasabe N, et al. Risk factors for erosive esophagitis: a cross-sectional study of a large number of Japanese males. J Gastroenterol. 2011;46(4):448–55.PubMedCrossRef Gunji T, Sato H, Iijima K, Fujibayashi K, Okumura M, Sasabe N, et al. Risk factors for erosive esophagitis: a cross-sectional study of a large number of Japanese males. J Gastroenterol. 2011;46(4):448–55.PubMedCrossRef
39.
Zurück zum Zitat Nozu T, Komiyama H. Clinical characteristics of asymptomatic esophagitis. J Gastroenterol. 2008;43(1):27–31.PubMedCrossRef Nozu T, Komiyama H. Clinical characteristics of asymptomatic esophagitis. J Gastroenterol. 2008;43(1):27–31.PubMedCrossRef
40.
Zurück zum Zitat Duroux P, Bauerfeind P, Emde C, Koelz HR, Blum AL. Early dinner reduces nocturnal gastric acidity. Gut. 1989;30(8):1063–7.PubMedCrossRef Duroux P, Bauerfeind P, Emde C, Koelz HR, Blum AL. Early dinner reduces nocturnal gastric acidity. Gut. 1989;30(8):1063–7.PubMedCrossRef
41.
Zurück zum Zitat Lanzon-Miller S, Pounder RE, McIsaac RL, Wood JR. The timing of the evening meal affects the pattern of 24-hour intragastric acidity. Aliment Pharmacol Ther. 1990;4(5):547–53.PubMedCrossRef Lanzon-Miller S, Pounder RE, McIsaac RL, Wood JR. The timing of the evening meal affects the pattern of 24-hour intragastric acidity. Aliment Pharmacol Ther. 1990;4(5):547–53.PubMedCrossRef
42.
Zurück zum Zitat Piesman M, Hwang I, Maydonovitch C, Wong RK. Nocturnal reflux episodes following the administration of a standardized meal. Does timing matter? Am J Gastroenterol. 2007;102(10):2128–34.PubMedCrossRef Piesman M, Hwang I, Maydonovitch C, Wong RK. Nocturnal reflux episodes following the administration of a standardized meal. Does timing matter? Am J Gastroenterol. 2007;102(10):2128–34.PubMedCrossRef
43.
Zurück zum Zitat Fass R, Tougas G. Functional heartburn: the stimulus, the pain, and the brain. Gut. 2002;51(6):885–92.PubMedCrossRef Fass R, Tougas G. Functional heartburn: the stimulus, the pain, and the brain. Gut. 2002;51(6):885–92.PubMedCrossRef
44.
Zurück zum Zitat Naliboff BD, Mayer M, Fass R, Fitzgerald LZ, Chang L, Bolus R, et al. The effect of life stress on symptoms of heartburn. Psychosom Med. 2004;66(3):426–34.PubMedCrossRef Naliboff BD, Mayer M, Fass R, Fitzgerald LZ, Chang L, Bolus R, et al. The effect of life stress on symptoms of heartburn. Psychosom Med. 2004;66(3):426–34.PubMedCrossRef
45.
Zurück zum Zitat Nojkov B, Rubenstein JH, Adlis SA, Shaw MJ, Saad R, Rai J, et al. The influence of co-morbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2008;27(6):473–82.PubMedCrossRef Nojkov B, Rubenstein JH, Adlis SA, Shaw MJ, Saad R, Rai J, et al. The influence of co-morbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2008;27(6):473–82.PubMedCrossRef
46.
Zurück zum Zitat Zheng Z, Nordenstedt H, Pedersen NL, Lagergren J, Ye W. Lifestyle factors and risk for symptomatic gastroesophageal reflux in monozygotic twins. Gastroenterology. 2007;132(1):87–95.PubMedCrossRef Zheng Z, Nordenstedt H, Pedersen NL, Lagergren J, Ye W. Lifestyle factors and risk for symptomatic gastroesophageal reflux in monozygotic twins. Gastroenterology. 2007;132(1):87–95.PubMedCrossRef
47.
Zurück zum Zitat Fass R. Effect of gastroesophageal reflux disease on sleep. J Gastroenterol Hepatol. 2010;25(Suppl 1):S41–4.PubMedCrossRef Fass R. Effect of gastroesophageal reflux disease on sleep. J Gastroenterol Hepatol. 2010;25(Suppl 1):S41–4.PubMedCrossRef
48.
Zurück zum Zitat Kusano M, Kouzu T, Kawano T, Ohara S. Nationwide epidemiological study on gastroesophageal reflux disease and sleep disorders in the Japanese population. J Gastroenterol. 2008;43(11):833–41.PubMedCrossRef Kusano M, Kouzu T, Kawano T, Ohara S. Nationwide epidemiological study on gastroesophageal reflux disease and sleep disorders in the Japanese population. J Gastroenterol. 2008;43(11):833–41.PubMedCrossRef
49.
Zurück zum Zitat Fujiwara Y, Higuchi K, Shiba M, Yamamori K, Watanabe Y, Sasaki E, et al. Differences in clinical characteristics between patients with endoscopy-negative reflux disease and erosive esophagitis in Japan. Am J Gastroenterol. 2005;100(4):754–8.PubMedCrossRef Fujiwara Y, Higuchi K, Shiba M, Yamamori K, Watanabe Y, Sasaki E, et al. Differences in clinical characteristics between patients with endoscopy-negative reflux disease and erosive esophagitis in Japan. Am J Gastroenterol. 2005;100(4):754–8.PubMedCrossRef
50.
Zurück zum Zitat Mishima I, Adachi K, Arima N, Amano K, Takashima T, Moritani M, et al. Prevalence of endoscopically negative and positive gastroesophageal reflux disease in the Japanese. Scand J Gastroenterol. 2005;40(9):1005–9.PubMedCrossRef Mishima I, Adachi K, Arima N, Amano K, Takashima T, Moritani M, et al. Prevalence of endoscopically negative and positive gastroesophageal reflux disease in the Japanese. Scand J Gastroenterol. 2005;40(9):1005–9.PubMedCrossRef
51.
Zurück zum Zitat Nocon M, Labenz J, Willich SN. Lifestyle factors and symptoms of gastro-oesophageal reflux—a population-based study. Aliment Pharmacol Ther. 2006;23(1):169–74.PubMedCrossRef Nocon M, Labenz J, Willich SN. Lifestyle factors and symptoms of gastro-oesophageal reflux—a population-based study. Aliment Pharmacol Ther. 2006;23(1):169–74.PubMedCrossRef
Metadaten
Titel
Lifestyle factors associated with gastroesophageal reflux disease in the Japanese population
verfasst von
Nobuyuki Matsuki
Tsuyoshi Fujita
Naoya Watanabe
Atsushi Sugahara
Akihiko Watanabe
Tsukasa Ishida
Yoshinori Morita
Masaru Yoshida
Hiromu Kutsumi
Takanobu Hayakumo
Hidekazu Mukai
Takeshi Azuma
Publikationsdatum
01.03.2013
Verlag
Springer Japan
Erschienen in
Journal of Gastroenterology / Ausgabe 3/2013
Print ISSN: 0944-1174
Elektronische ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-012-0649-1

Weitere Artikel der Ausgabe 3/2013

Journal of Gastroenterology 3/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.